Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?
- 17 September 2023
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 40 (2) , 213-219
Abstract
Growth and differentiation factor-15 (GDF-15) correlates with worse outcome of many tumours and any cause mortality. Data about its role in lymphoproliferative neoplasms (LPN) are scarce. Our research aimed to reveal the correlation between GDF-15 and standard laboratory parameters of LPN activity, and to get insight into the possible value of this cytokine assessment in lymphoma patients. Prospective research included 40 patients treated for aggressive or indolent LPN, and 31 with indolent LPN on “watch and wait” regimen. Analyses were performed before and after treatment in treated patients and on two separate occasions in the “watch and wait” group. ELISA technique with R&D assays according to the manufacturer manual, from stored sera at − 70 °C was used for GDF-15 level measurement. Statistical analyses were performed by IBM SPSS Statistics 22 using descriptive and inferential statistics. As appropriate, differences between groups were assessed by two tailed t-test, Mann–Whitney or x2 test. Spearman Rank Order Correlation was done to correlate GDF-15 with standard laboratory markers of disease activity. All tests are two-tailed with significance level p < 0. 05. GDF-15 (p = 0.028) and fibrinogen (p = 0.001) concentrations increased after treatment in indolent lymphoma patients while β2 microglobulin decreased (p < 0.001). GDF-15 positively correlated with β2microglobulin before (p < 0.001) and after (p = 0.031) therapy. There were no differences in any of the aforementioned parameters in the “watch and wait” group during observation. A positive correlation between GDF-15 and β2 microglobulin in patients with indolent LPN who need treatment suggests potential value in risk assessment.Keywords
This publication has 25 references indexed in Scilit:
- The 2016 revision of the World Health Organization classification of lymphoid neoplasmsBlood, 2016
- Tissue-based map of the human proteomeScience, 2015
- [Expression of serum GDF15 and its clinical significance in multiple myeloma patients].2014
- Adverse events and technical complaints related to central venous catheters marketed in BrazilRevista Brasileira de Ginecologia e Obstetrícia, 2013
- Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple MyelomaCancer Research, 2012
- Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortalityAging Cell, 2010
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serumProceedings of the National Academy of Sciences, 2003
- Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer PatientsJournal of International Medical Research, 2000
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences, 1997
- Fibrinogen kinetics in patients with neoplastic diseaseCancer, 1978